Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Titel:
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Auteur:
McCartney, Amelia Biagioni, Chiara Schiavon, Gaia Bergqvist, Mattias Mattsson, Karin Migliaccio, Ilenia Benelli, Matteo Romagnoli, Dario Bonechi, Martina Boccalini, Giulia Pestrin, Marta Galardi, Francesca De Luca, Francesca Biganzoli, Laura Piccart, Martine Gradishar, William J. Chia, Stephen Di Leo, Angelo Malorni, Luca